Cell Stem Cell
Volume 16, Issue 6, 4 June 2015, Pages 576-577
Journal home page for Cell Stem Cell

Preview
Regenerative Medicines for Remyelination: From Aspiration to Reality

https://doi.org/10.1016/j.stem.2015.05.010Get rights and content
Under an Elsevier user license
open archive

Stimulating an endogenous regenerative response is a powerful approach for potential treatment of chronic demyelinating diseases such as multiple sclerosis. Recently in Nature, Najm et al. (2015) identified two clinically relevant, FDA-approved compounds that promote oligodendrocyte progenitor cell differentiation and induce remyelination in demyelinating disease models.

Cited by (0)